[Fine-needle aspiration cell pathology for diagnosis of intrathoracic extramedullary hematopoiesis presenting as a posterior mediastinal tumor: a case report]

[细针穿刺细胞病理学诊断胸内髓外造血表现为后纵隔肿瘤:病例报告]

阅读:1

Abstract

To study the feasibility of in a A patient with extramedullary hematopoiesis presenting as a posterior mediastinal tumor underwent fine-needle aspiration for cell pathology diagnosis. The primary locus of a posterior mediastinal extramedullary hematopoiesis was examined with Papanicolaou staining and HE staining, and the expressions of cytokeratin, epithelial membrane antigen (EMA), terminal deoxynucleotidyl transferase, CD3, CD20, anaplastic lymphoma kinase, CD34, CD235a, myeloperoxidase, CD61, P53, CD30, S-100, CD1a, and Ki-67 with immunohistochemistry. The results were analyzed of bone marrow biopsy and cell smears, examination of chromosome structure and number, and detection of BCR/ABL fusion gene using fluorescence in situ hybridization. Examination of cell pathology of fine-needle aspiration in the posterior mediastinal focus revealed scatter cells of heterogeneous sizes consisting mainly of erythroid cells, and granulocytes and erythroid cells at different stages and lobulated large mature megakaryocytes were found. The eythroid cells in the core biopsy tissue were distributed in multiple cell islands. Immunohistochemistry showed positive results for erythroid cell CD235a, granulocyte MPO, megakaryocyte CD61, and Ki-67 (about 90%). Examination of the bone barrow biopsy tissue and cell smear also showed the changes of hyperplastic anemia without clone structure or abnormal number of the chromosomes, and no BCR/ABL fusion gene was detected by fluorescence in situ hybridization. Fine-needle aspiration cell pathology combined with the patient's clinical data allows the diagnosis of extramedullary hematopoiesis in the rare site of the posterior mediastinum.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。